Valuation (9%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -93.75 | 12.52 |
| PEG Ratio (TTM) | -5.43 | 1.68 |
| P/S Ratio (TTM) | 6.72 | 1.32 |
| P/B Ratio (TTM) | 2.15 | 1.55 |
| P/FCF Ratio (TTM) | -4.99 | 6.42 |
| Price to 5YR AVG Earnings Ratio | N/A | 8.51 |
| Price to 5YR AVG FCF Ratio | N/A | 1.59 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.22% | 1.05% |
| ROE (TTM) | -3.02% | 11.72% |
| Net Profit Margin (TTM) | -6.13% | 8.57% |
| ROIC 5YR AVG | N/A | -0.41% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -141.21% | 992.68% | N/A |
| Revenue | 62.24% | 42.99% | N/A |
| Net Income | -42.35% | 991.94% | N/A |
| Cash Flow | -2,444.92% | 13.83% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.84 | 5.99 |
| Quick Ratio (TTM) | 1.84 | 15.42 |
| D/E Ratio (TTM) | 0.77 | 0.61 |
| Interest Coverage (TTM) | 0.97 | 12.30 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 2.03 | 0.52 |
| LTL to 5YR AVG FCF | N/A | -3.98 |
| Shares Outstanding Growth 5YR AVG | N/A | -3.63% |